United States · FDA National Drug Code directory
Biktarvy
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61958-2505_261dcc2a-c849-46b1-abf6-4981ed2c60bc
- Product NDC
- 61958-2505
- Form
- TABLET
- Composition / generic term
- bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
- Labeler
- Gilead Sciences, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20211007
- Source listing expiry
- 20271231
Source-listed ingredients
- BICTEGRAVIR SODIUM — 30 mg/1
- EMTRICITABINE — 120 mg/1
- TENOFOVIR ALAFENAMIDE FUMARATE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE, PLASTIC (61958-2505-1) · 61958-2505-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →